drug discovery

Membraneless droplet like organelles known as condensates are changing the way some scientists approach drug discovery.

The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.

LIVE March 29th, 2022 at 2:30 PM
Proteolysis targeting chimeras (PROTACs) are promising agents for developing novel anticancer drugs.

LIVE February 18th, 2022 at 10:00 AM ET
Careful study of the neurobiology of mental health leads to insights on the complexities of the human mind.

Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?

The long history of insulin discovery and its development for treating diabetes is marked with determination and serendipity, collaboration and controversy.

CRISPR gene editing directly and indirectly drives advances in cardiovascular disease therapeutic development.

LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.

LIVE September 22nd, 2021 at 2:30 PM ET
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.

Beyond the buzz, is AI just another research tool?